Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,394.82 -30.03 -0.18%
S&P 500 1,862.76 0.45 0.02%
NASDAQ 4,081.04 -5.18 -0.13%
Ticker Volume Price Price Delta
STOXX 50 3,155.68 16.42 0.52%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,417.53 -0.15 -0.00%
TOPIX 1,166.59 0.04 0.00%
HANG SENG 22,760.24 64.23 0.28%

Mindray Statement on Masimo Lawsuit Against Mindray



             Mindray Statement on Masimo Lawsuit Against Mindray

PR Newswire

SHENZHEN, China, Jan. 7, 2013

SHENZHEN, China, Jan. 7, 2013 /PRNewswire-FirstCall/ -- Mindray Medical
International Limited ("Mindray," NYSE: MR), a leading developer, manufacturer
and marketer of medical devices worldwide, today announced a statement on
Masimo Corporation's lawsuit against Mindray.

On December 21, 2012, Masimo Corporation ("Masimo") brought an action in the
United States District Court for the Central District of California against
Mindray DS USA Inc. and Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Masimo alleges that Mindray DS USA, Inc.'s U.S. Beneview pulse oximeters and
sensors infringe its nine asserted patents relating to pulse oximeters and
sensors, and that Shenzhen Mindray Bio-Medical Electronics Co., Ltd breached
its Purchase and License Agreement dated November 13, 2002, as amended, by
failing to use best efforts to promote adoption of Masimo's oximeter
technology. In addition to monetary damages, Masimo is seeking injunctive
relief preventing further sale of Beneview products incorporating Mindray
oximetry boards in the United States.

Mindray intends to vigorously defend the actions.

About Mindray

We are a leading developer, manufacturer and marketer of medical devices
worldwide. We maintain our global headquarters in Shenzhen, China, U.S.
headquarters in Mahwah, New Jersey and multiple sales offices in major
international markets. From our main manufacturing and engineering base in
China, we supply through our worldwide distribution network a broad range of
products across three primary business segments, namely patient monitoring and
life support, in-vitro diagnostic, and medical imaging systems. For more
information, please visit http://ir.mindray.com.

For investor and media inquiries please contact:

In the U.S:
Hoki Luk
Western Bridge, LLC
Tel: +1-646-808-9150
Email: hoki.luk@westernbridgegroup.com

In China:
Cathy Gao
Mindray Medical International Limited
Tel: +86-755-8188-8023
Email: cathy.gao@mindray.com

SOURCE Mindray Medical International Limited

Website: http://ir.mindray.com
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement